Criteria Bio Ventures — Full Portfolio

Adaptam Therapeutics develops antibody-based cancer immunotherapies, including antibody-drug conjugates and bispecific antibodies, that target the immunosuppressive myeloid tumor microenvironment via novel targets such as glycan-binding proteins and Siglecs.

BiotechHealthtechSan Sebastián, ES

Asis Palazon(CEO/CSO & Founder)in

NRG Therapeutics is a biotech company developing small-molecule drugs targeting the mitochondrial permeability transition pore (mPTP) for neurodegenerative diseases such as ALS and Parkinson's.

BiotechHealthtechLongevity

Neil Miller(CEO)inRichard Rutter(CSO)inGrant Hawthorne(COO)inClaus Sundgreen(Chief Medical Officer)inPaul Thompson(CDO)in

BoardJonathan Savidge(Independent Non Executive Chair)

Co-investorsNovartis Venture FundSV Health InvestorsBritish Business BankM VenturesDementia Discovery Fund

AELIX Therapeutics is a company developing a therapeutic HIV vaccine intended for use in HIV cure and eradication strategies.

BiotechHealthtechBarcelona, ES

Co-investorsYsios Capital

aptaTargets develops aptamer-based therapeutics and diagnostics for cerebrovascular diseases, with a lead program (ApTOLL) targeting stroke treatment.

AI & Machine LearningBiotechHealthtechMedical DevicesMadrid, ES

David(Co-Founder & CEO)Maria Eugenia(Co-Founder & CFO)

Circe Scientific provides DMPK (drug metabolism and pharmacokinetics) and PK/PD consulting for biotech, pharmaceutical, and venture capital clients working in drug discovery and development.

AgTechBiotechHealthtechLongevityWellness & FitnessMallorca, ES

Fernando BarreraDr. Rafel Prohens

Development of point-of-care diagnostic testing systems.

Biopharmaceutical focused on developing therapeutic aptamers.

Predicting bone metastasis to improve cancer patients' quality of life.

Experimental screenings to find new polymorphs and co-crystals of active pharmaceutical ingredients.

Unlocking intra-cellular drug targets.

Novel in vitro diagnostic biomarker for the early detection of cardiac ischemia.

Next-generation immune cell engagers for cancer.

A novel mitochondrial-targeted therapy for neurodegenerative diseases.

Safer and more effective treatments for cancer patients.

Thymus-based therapies for immune-mediated diseases.

Cytospire Therapeutics develops multispecific antibodies and next-generation γδ T cell engagers designed to direct innate and adaptive immune effector cells as an alternative to CD3-based engagers.

BiotechHealthtech

Co-investorsLifeArc VenturesMedical Incubator Japan K.K.Modi VenturesPathway BioventuresSound Bioventures

Devicare sells nutritional and health products, including supplements and monitoring devices for conditions such as kidney stones and urinary infections.

ConsumerHealthtechWellness & Fitness

Co-investorsCapital CellEmesa Corporación EmpresarialShip2B

InBioMotion offers a biomarker test that analyzes MAF gene levels to assess prognosis and guide personalized bisphosphonate treatment in early breast cancer patients.

BiotechDigital HealthMedical Devices

BoardProf Rob E. Coleman(Chairman)

Co-investorsYsios CapitalAlta Life SciencesAsabys Partners

Clinical-stage biotech developing therapies for orphan CNS diseases; lead program MIN-102 in trials for X-linked Adrenoleukodystrophy and Friedreich's Ataxia.

Co-investorsFund+

Minoryx is a registration-stage biotech company developing novel therapies for severe, orphan genetic diseases of the central nervous system, with a lead compound (leriglitazone) in clinical trials for conditions including cerebral adrenoleukodystrophy, Friedreich's Ataxia, and Rett syndrome.

BiotechDeep TechHealthtechMedical DevicesMataró, ES

Marc Martinell(Co-Founder & Chief Executive Officer)

Co-investorsChiesi VenturesFund+Invivo Capital PartnersKurma PartnersRoche Venture FundYsios Capital+1 more

Oncology-focused company whose clinical assets moved to Boehringer Ingelheim and AstraZeneca.

Clinical assets for cancer treatment.

Nuubo offers a wireless, non-invasive cardiac monitoring technology (aECG) based on textile electrodes for medium- and long-term remote heart monitoring.

Digital HealthHardwareMedical Devices

Co-investorsCapital CellFides Capital

CSL is a biotechnology company that develops and manufactures plasma-derived and other therapies, including biotherapies for rare and serious diseases, vaccines, and treatments for iron deficiency and kidney disease.

BiotechHealthtechMedical Devices

Joan Perello Bestard(Founder)inCris Calsadain

Co-investorsAndera PartnersInvivo Capital PartnersYsios Capital

SpliceBio develops genetic medicines using a proprietary protein splicing platform to treat diseases caused by mutations in large genes.

BiotechDeep TechDigital HealthBarcelona, ES

Dr. Vila-Perelló(CEO)Dr. Frutos(Co-founder)

Co-investorsNovartis Venture FundRoche Venture FundSanofi VenturesYsios CapitalAsabys PartnersNew Enterprise Associates (NEA)+2 more

Tolerance is a compliance platform that runs continuous automated checks against the NIST 800-171 standard and collects assessor-ready evidence for teams handling Controlled Unclassified Information (CUI).

CybersecurityGovTechSaaS

Co-investorsDorm RoomAmadeus Capital PartnersBen Franklin Technology PartnersBioAdvanceColumbus Venture PartnersEast Innovate+4 more

BiotechPhiladelphia, US

Francisco Leon(Executive Officer, Director)Philip Ball(Executive Officer, Director)Justin Vogel(Executive Officer, Director)

BoardDamia Tormo Carulla(Director)Pablo Cironi(Director)inRobert Goldstein(Director)

Co-investorsBioAdvance

Co-investorsBullnet Gestión SGECR, S. A.Criteria Venture TechIntel CapitalTEL Venture Capital, Inc.